Skip to content
Clinical Trials – home
RomaniaBack to Romania

Clinical trials in Reghin – page 4

138 clinical trials in Reghin, Romania. Every trial is listed in the EU Clinical Trials Register and updated daily.

RomaniaOur site in RomaniaStudii.Clinice.ro(opens in a new tab)
Reghin at a glance
138
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

138 trials in Reghin

Open in trial search

Study on Ferric Derisomaltose for Patients with Iron Deficiency and Chronic Heart Failure

Registered drugNo placebo
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Ferric Derisomaltose
  • Sponsor:Pharmacosmos A/S

Study of DNTH103 Treatment for Adults with Chronic Inflammatory Demyelinating Polyneuropathy: Comparing Effectiveness with Placebo

Investigational
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:DNTH103
  • Sponsor:Dianthus Therapeutics Inc.
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Colesevelam hydrochloride
  • Sponsor:Cosmo Technologies Limited

Study on the Effectiveness and Safety of Efgartigimod IV for Adults with Primary Immune Thrombocytopenia

Registered drug
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Efgartigimod Alfa
  • Sponsor:Argenx

Study of deucrictibant tablets for prevention of hereditary angioedema attacks in adults and adolescents

InvestigationalNo placebo
Countries:RomaniaRomania
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Deucrictibant
  • Sponsor:Pharvaris Netherlands B.V.

Myelofibrosis

Recruiting

Study on Adding Navtemadlin to Ruxolitinib for Patients with Myelofibrosis and Suboptimal Response to Ruxolitinib

Registered drug
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Navtemadlin
  • Sponsor:Kartos Therapeutics Inc.

Study on the Safety and Benefits of Recombinant Human Plasma Gelsolin for Patients with Moderate-to-Severe Acute Respiratory Distress Syndrome (ARDS)

Investigational
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Human Plasma Gelsolin, Recombinant
  • Sponsor:Bioaegis Therapeutics Inc.

Study on the Effectiveness and Safety of Metronidazole, Neomycin Sulfate, and Nystatin for Women with Bacterial Vaginosis and Yeast Infections

Registered drugNo placebo
Countries:RomaniaRomania
  • Participants:18–64 years
  • Substances:Metronidazole
  • Sponsor:Antibiotice S.A.

Pneumonia

Recruiting

Study on the Effects of Oseltamivir and Drug Combination for Patients with Pneumonia

Registered drugNo placebo
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Baloxavir Marboxil
  • Sponsor:University Of Oxford

Hyperkalaemia

Recruiting

Study on the Safety and Effectiveness of Sodium Zirconium Cyclosilicate for Children with High Potassium Levels

Registered drugNo placebo
Countries:RomaniaRomania
  • Participants:0–17 years
  • Substances:Sodium Zirconium Cyclosilicate
  • Sponsor:AstraZeneca AB

Study on the Effectiveness and Safety of Treprostinil and Drug Combination for Patients with Pulmonary Arterial Hypertension (Group I)

Registered drugNo placebo
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Treprostinil
  • Sponsor:Aop Orphan Pharmaceuticals GmbH

Study on the Safety of Long-Term Use of Deucrictibant for Treating Hereditary Angioedema Attacks in Patients with C1-Inhibitor Deficiency

Registered drug
Countries:RomaniaRomania
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Deucrictibant
  • Sponsor:Pharvaris Netherlands B.V.

Other cities in Romania

The busiest research cities in the country

All 63 cities in Romania

Clinical research in Reghin

What the registry says about research in the country

01 Immune System Diseases and Dermatology

In Reghin, clinical trial activity includes research in immune system diseases with a strong focus on moderate to severe plaque psoriasis. These studies are designed to evaluate the long-term safety and treatment performance of new and existing therapies, helping clarify how well they support disease control in everyday care.

  • Moderate to severe plaque psoriasis
  • Long-term treatment safety
  • Comparison of therapeutic effectiveness

This area reflects ongoing efforts to improve care options for chronic inflammatory skin disease while monitoring overall treatment safety.

02 Nutritional and Metabolic Diseases

Another active research area in Reghin is nutritional and metabolic diseases, especially studies involving type 2 diabetes and overweight or obesity. The trials are focused on testing whether new therapies can better lower blood sugar, reduce body weight, and improve metabolic control.

  • Type 2 diabetes
  • Overweight or obesity
  • Blood sugar control
  • Weight management

These studies aim to support better treatment strategies for people living with common, long-term metabolic conditions.

03 Diabetes and Cardiometabolic Research

Clinical trials in this category are examining treatments for type 2 diabetes in people who need improved glycaemic control. The research is centered on whether newer options can offer stronger effects on HbA1c and overall cardiometabolic health compared with established therapies.

  • Type 2 diabetes
  • HbA1c improvement
  • Metabolic treatment effectiveness

This work supports the search for more effective ways to manage diabetes in routine clinical practice.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.